These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 27120570)

  • 41. Association Between Complementary and Alternative Medicine Use and Breast Cancer Chemotherapy Initiation: The Breast Cancer Quality of Care (BQUAL) Study.
    Greenlee H; Neugut AI; Falci L; Hillyer GC; Buono D; Mandelblatt JS; Roh JM; Ergas IJ; Kwan ML; Lee M; Tsai WY; Shi Z; Lamerato L; Kushi LH; Hershman DL
    JAMA Oncol; 2016 Sep; 2(9):1170-6. PubMed ID: 27243607
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development of a self-efficacy scale for adolescents and young adults with inflammatory bowel disease.
    Izaguirre MR; Keefer L
    J Pediatr Gastroenterol Nutr; 2014 Jul; 59(1):29-32. PubMed ID: 24590216
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Doctor communication quality and Friends' attitudes influence complementary medicine use in inflammatory bowel disease.
    Mountifield R; Andrews JM; Mikocka-Walus A; Bampton P
    World J Gastroenterol; 2015 Mar; 21(12):3663-70. PubMed ID: 25834335
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Complementary and alternative medicine in patients with inflammatory bowel disease: A survey performed in a tertiary center in Chile.
    Fernández A; Simian D; Quera R; Flores L; Ibáñez P; Lubascher J; Figueroa C; Kronberg U; Pizarro G; Fluxá D
    Complement Ther Med; 2018 Oct; 40():77-82. PubMed ID: 30219473
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rates and Reasons for Nonuse of Prescription Medication for Inflammatory Bowel Disease in a Referral Clinic.
    Bhasin S; Singh H; Targownik LE; Israeli E; Bernstein CN
    Inflamm Bowel Dis; 2016 Apr; 22(4):919-24. PubMed ID: 26933748
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Probiotic and prebiotic use in patients with inflammatory bowel disease: a case-control study.
    Hedin CR; Mullard M; Sharratt E; Jansen C; Sanderson JD; Shirlaw P; Howe LC; Djemal S; Stagg AJ; Lindsay JO; Whelan K
    Inflamm Bowel Dis; 2010 Dec; 16(12):2099-108. PubMed ID: 20848469
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Manitoba Inflammatory Bowel Disease Cohort Study: a prospective longitudinal evaluation of the use of complementary and alternative medicine services and products.
    Rawsthorne P; Clara I; Graff LA; Bernstein KI; Carr R; Walker JR; Ediger J; Rogala L; Miller N; Bernstein CN
    Gut; 2012 Apr; 61(4):521-7. PubMed ID: 21836028
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Covert dose reduction is a distinct type of medication non-adherence observed across all care settings in inflammatory bowel disease.
    Mountifield R; Andrews JM; Mikocka-Walus A; Bampton P
    J Crohns Colitis; 2014 Dec; 8(12):1723-9. PubMed ID: 25263934
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Complementary and alternative medicine use by Canadian patients with inflammatory bowel disease: results from a national survey.
    Hilsden RJ; Verhoef MJ; Best A; Pocobelli G
    Am J Gastroenterol; 2003 Jul; 98(7):1563-8. PubMed ID: 12873578
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Incidence of self-prescribed oral complementary and alternative medicine use by patients with gastrointestinal diseases.
    Kong SC; Hurlstone DP; Pocock CY; Walkington LA; Farquharson NR; Bramble MG; McAlindon ME; Sanders DS
    J Clin Gastroenterol; 2005 Feb; 39(2):138-41. PubMed ID: 15681910
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pregnant women with IBD are more likely to be adherent to biologic therapies than other medications.
    Lee S; Seow CH; Adhikari K; Metcalfe A
    Aliment Pharmacol Ther; 2020 Mar; 51(5):544-552. PubMed ID: 31797416
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Complementary and alternative medicine use in adolescents with inflammatory bowel disease and juvenile idiopathic arthritis.
    Nousiainen P; Merras-Salmio L; Aalto K; Kolho KL
    BMC Complement Altern Med; 2014 Apr; 14():124. PubMed ID: 24708564
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of complementary and alternative medicine in Swedish patients with inflammatory bowel disease: a controlled study.
    Oxelmark L; Lindberg A; Löfberg R; Sternby B; Eriksson A; Almer S; Befrits R; Fossum B; Karlén P; Broström O; Tysk C;
    Eur J Gastroenterol Hepatol; 2016 Nov; 28(11):1320-8. PubMed ID: 27472271
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Concurrent use of complementary and alternative medicine with antiretroviral therapy reduces adherence to HIV medications.
    Ekwunife OI; Oreh C; Ubaka CM
    Int J Pharm Pract; 2012 Oct; 20(5):340-3. PubMed ID: 22953773
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Patient trust-in-physician and race are predictors of adherence to medical management in inflammatory bowel disease.
    Nguyen GC; LaVeist TA; Harris ML; Datta LW; Bayless TM; Brant SR
    Inflamm Bowel Dis; 2009 Aug; 15(8):1233-9. PubMed ID: 19177509
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adolescent transition clinic in inflammatory bowel disease: quantitative assessment of self-efficacy skills.
    Yerushalmy-Feler A; Ron Y; Barnea E; Nachum A; Matalon S; Dali-Levy M; Dotan I; Cohen S
    Eur J Gastroenterol Hepatol; 2017 Jul; 29(7):831-837. PubMed ID: 28230561
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Medication non-adherence in adult patients affected by inflammatory bowel disease: a critical review and update of the determining factors, consequences and possible interventions.
    Lenti MV; Selinger CP
    Expert Rev Gastroenterol Hepatol; 2017 Mar; 11(3):215-226. PubMed ID: 28099821
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Remission in Pediatric Inflammatory Bowel Disease Correlates With Prescription Refill Adherence Rates.
    Samson CM; Mager D; Frazee S; Yu F
    J Pediatr Gastroenterol Nutr; 2017 Apr; 64(4):575-579. PubMed ID: 27299424
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use of Complementary and Alternative Medicine in Inflammatory Bowel Disease Around the World.
    Zezos P; Nguyen GC
    Gastroenterol Clin North Am; 2017 Dec; 46(4):679-688. PubMed ID: 29173516
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predictors of health-related quality of life and adherence in Crohn's disease and ulcerative colitis: implications for clinical management.
    Tabibian A; Tabibian JH; Beckman LJ; Raffals LL; Papadakis KA; Kane SV
    Dig Dis Sci; 2015 May; 60(5):1366-74. PubMed ID: 25559754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.